REPORT ID 521

EMEA (Europe, Middle East and Africa) Proton Pump Inhibitors (PPIs) Market Report 2017

Publish Date
04-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the EMEA Proton Pump Inhibitors (PPIs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Proton Pump Inhibitors (PPIs) for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Proton Pump Inhibitors (PPIs) market competition by top manufacturers/players, with Proton Pump Inhibitors (PPIs) sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Pfizer
    Janssen
    Eisai
    Eli Lilly
    Cadila Pharmaceuticals
    Santarus
    Wyeth
    Changzhou Siyao Pharmaceuticals
    Yangzhou Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Pantoprazole
    Omeprazole
    Lansoprazole
    Esomeprazole
    Rabeprazole
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Proton Pump Inhibitors (PPIs) Market Report 2017
1 Proton Pump Inhibitors (PPIs) Overview
    1.1 Product Overview and Scope of Proton Pump Inhibitors (PPIs)
    1.2 Classification of Proton Pump Inhibitors (PPIs)
        1.2.1 EMEA Proton Pump Inhibitors (PPIs) Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Proton Pump Inhibitors (PPIs) Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Pantoprazole
        1.2.4 Omeprazole
        1.2.5 Lansoprazole
        1.2.6 Esomeprazole
        1.2.7 Rabeprazole
        1.2.8 Other
    1.3 EMEA Proton Pump Inhibitors (PPIs) Market by Application/End Users
        1.3.1 EMEA Proton Pump Inhibitors (PPIs) Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 EMEA Proton Pump Inhibitors (PPIs) Market by Region
        1.4.1 EMEA Proton Pump Inhibitors (PPIs) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Proton Pump Inhibitors (PPIs) (2012-2022)
        1.5.1 EMEA Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Proton Pump Inhibitors (PPIs) Revenue and Growth Rate (2012-2022)

2 EMEA Proton Pump Inhibitors (PPIs) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Proton Pump Inhibitors (PPIs) Market Competition by Players/Manufacturers
        2.1.1 EMEA Proton Pump Inhibitors (PPIs) Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Proton Pump Inhibitors (PPIs) Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Proton Pump Inhibitors (PPIs) Sale Price by Players (2012-2017)
    2.2 EMEA Proton Pump Inhibitors (PPIs) (Volume and Value) by Type/Product Category
        2.2.1 EMEA Proton Pump Inhibitors (PPIs) Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Proton Pump Inhibitors (PPIs) Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Proton Pump Inhibitors (PPIs) Sale Price by Type (2012-2017)
    2.3 EMEA Proton Pump Inhibitors (PPIs) (Volume) by Application
    2.4 EMEA Proton Pump Inhibitors (PPIs) (Volume and Value) by Region
        2.4.1 EMEA Proton Pump Inhibitors (PPIs) Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Proton Pump Inhibitors (PPIs) Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Proton Pump Inhibitors (PPIs) Sales Price by Region (2012-2017)

3 Europe Proton Pump Inhibitors (PPIs) (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Proton Pump Inhibitors (PPIs) Sales and Value (2012-2017)
        3.1.1 Europe Proton Pump Inhibitors (PPIs) Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Proton Pump Inhibitors (PPIs) Revenue and Growth Rate (2012-2017)
    3.2 Europe Proton Pump Inhibitors (PPIs) Sales and Market Share by Type
    3.3 Europe Proton Pump Inhibitors (PPIs) Sales and Market Share by Application
    3.4 Europe Proton Pump Inhibitors (PPIs) Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Proton Pump Inhibitors (PPIs) Sales Volume by Countries (2012-2017)
        3.4.2 Europe Proton Pump Inhibitors (PPIs) Revenue by Countries (2012-2017)
        3.4.3 Germany Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        3.4.4 France Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        3.4.5 UK Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        3.4.6 Russia Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        3.4.7 Italy Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)

4 Middle East Proton Pump Inhibitors (PPIs) (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Proton Pump Inhibitors (PPIs) Sales and Value (2012-2017)
        4.1.1 Middle East Proton Pump Inhibitors (PPIs) Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Proton Pump Inhibitors (PPIs) Revenue and Growth Rate (2012-2017)
    4.2 Middle East Proton Pump Inhibitors (PPIs) Sales and Market Share by Type
    4.3 Middle East Proton Pump Inhibitors (PPIs) Sales and Market Share by Application
    4.4 Middle East Proton Pump Inhibitors (PPIs) Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Proton Pump Inhibitors (PPIs) Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Proton Pump Inhibitors (PPIs) Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        4.4.4 Israel Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        4.4.5 UAE Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        4.4.6 Iran Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)

5 Africa Proton Pump Inhibitors (PPIs) (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Proton Pump Inhibitors (PPIs) Sales and Value (2012-2017)
        5.1.1 Africa Proton Pump Inhibitors (PPIs) Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Proton Pump Inhibitors (PPIs) Revenue and Growth Rate (2012-2017)
    5.2 Africa Proton Pump Inhibitors (PPIs) Sales and Market Share by Type
    5.3 Africa Proton Pump Inhibitors (PPIs) Sales and Market Share by Application
    5.4 Africa Proton Pump Inhibitors (PPIs) Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Proton Pump Inhibitors (PPIs) Sales Volume by Countries (2012-2017)
        5.4.2 Africa Proton Pump Inhibitors (PPIs) Revenue by Countries (2012-2017)
        5.4.3 South Africa Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Proton Pump Inhibitors (PPIs) Sales and Growth Rate (2012-2017)

6 EMEA Proton Pump Inhibitors (PPIs) Manufacturers/Players Profiles and Sales Data
    6.1 AstraZeneca
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Janssen
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Janssen Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Eisai
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eisai Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Cadila Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Cadila Pharmaceuticals Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Santarus
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Santarus Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Wyeth
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Wyeth Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Changzhou Siyao Pharmaceuticals
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Changzhou Siyao Pharmaceuticals Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Yangzhou Pharmaceutical
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Proton Pump Inhibitors (PPIs) Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Yangzhou Pharmaceutical Proton Pump Inhibitors (PPIs) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Proton Pump Inhibitors (PPIs) Manufacturing Cost Analysis
    7.1 Proton Pump Inhibitors (PPIs) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Proton Pump Inhibitors (PPIs)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Proton Pump Inhibitors (PPIs) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Proton Pump Inhibitors (PPIs) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Proton Pump Inhibitors (PPIs) Market Forecast (2017-2022)
    11.1 EMEA Proton Pump Inhibitors (PPIs) Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Proton Pump Inhibitors (PPIs) Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Proton Pump Inhibitors (PPIs) Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Proton Pump Inhibitors (PPIs) Price and Trend Forecast (2017-2022)
    11.2 EMEA Proton Pump Inhibitors (PPIs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Proton Pump Inhibitors (PPIs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Proton Pump Inhibitors (PPIs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Proton Pump Inhibitors (PPIs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Proton Pump Inhibitors (PPIs) Sales Forecast by Type (2017-2022)
    11.7 EMEA Proton Pump Inhibitors (PPIs) Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer